Search Results - "Glotzer, Jana"

Prediction of Rehospitalization and Death in Severe Heart Failure by Physicians and Nurses of the ESCAPE Trial by Yamokoski, Laura M., RN, BSN, Hasselblad, Vic, PhD, Moser, Debra K., DNSc, Binanay, Cynthia, BSN, Conway, Ginger A., MSN, CNP, Glotzer, Jana M., MSN, CNP, Hartman, Karen A., RN, BSN, Stevenson, Lynne W., MD, Leier, Carl V., MD

“…Abstract Background The predictive accuracy of physician investigators and nurse coordinators in estimating the risk of rehospitalization and death was…”
Get full text

Evolution of Biomarker Guided Therapy for Heart Failure: Current Concepts and Trial Evidence by Pruett, Amanda E, Lee, Amanda K, Patterson, J Herbert, Schwartz, Todd A, Glotzer, Jana M, Adams, Jr, Kirkwood F

“…Optimizing management of patients with heart failure remains quite challenging despite many significant advances in drug and device therapy for this syndrome…”
Get full text

Changes in Resting and Maximal Exercise Heart Rate during Dosing of Beta Blocker Therapy in Patients with Systolic Heart Failure by Ghali, Jalal K, Pina, Ileana L, Chiong, Jun R, Lenihan, Daniel J, Wagoner, Lynne E, Dunlap, Stephanie H, Dupree, Carla A, Van Bakel, Adrian B, Glotzer, Jana M, Patterson, J. Herbert, Adams, Kirkwood F

Get full text

PILOT STUDY OF THE RELATIONSHIP OF AMBIENT COPEPTIN TO THE AQUARETIC EFFECTS OF TOLVAPTAN IN PATIENTS WITH HEART FAILURE by Adams, Kirkwood F, Glotzer, Jana, Lee, Amanda K, Schwartz, Todd, Lin, Tess E, Patterson, J. Herbert

“…Background: Tolvaptan, an arginine vasopressin (AVP) antagonist, may be a novel therapy for congestive heart failure (CHF) but AVP activation is not uniform…”
Get full text

Trastuzumab-induced cardiotoxicity by Moss, Lisa Stegall, Starbuck, Mandy Fields, Mayer, Deborah K, Harwood, Elaine Brooks, Glotzer, Jana

“…To review trastuzumab-related cardiotoxic effects in the breast cancer adjuvant setting, present a system for pretreatment screening for cardiovascular risk…”
Get full text